CD4 and head and neck squamous cell carcinoma: The proportions of CD4+CD3+ and CD8+CD3+ T cells and CD19+ and CD5+CD19+ B cells were examined in PBMCs collected from 21 of 28 patients with HNSCC prior, during, and following combination radiotherapy (Table 1).